Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer's disease

Owens LV, Benedetto A, Dawson N, Gaffney CJ, Parkin ET.

Brain Res. 2021 Feb 15;1753:147264. doi: 10.1016/j.brainres.2020.147264. Epub 2021 Jan 7.

Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present)

Bortolami M, Rocco D, Messore A, Di Santo R, Costi R, Madia VN, Scipione L, Pandolfi F.

Expert Opin Ther Pat. 2021 May;31(5):399-420. doi: 10.1080/13543776.2021.1874344. Epub 2021 Jan 14.

Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer's Disease

Wolfe MS.

Molecules. 2021 Jan 13;26(2):388. doi: 10.3390/molecules26020388.

β-lactam antibiotics to tame down molecular pathways of Alzheimer's disease

Kumari S, Deshmukh R.

Eur J Pharmacol. 2021 Mar 15;895:173877. doi: 10.1016/j.ejphar.2021.173877. Epub 2021 Jan 14.

A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease

Castagna A, Fabbo A, Manzo C, Lacava R, Ruberto C, Ruotolo G.

J Alzheimers Dis. 2021;79(4):1509-1515. doi: 10.3233/JAD-201211.

Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease

Kabir MT, Uddin MS, Zaman S, Rahman MS, Behl T, Ahmad A, Hafeez A, Perveen A, Ashraf GM.

Curr Pharm Des. 2021;27(22):2635-2647. doi: 10.2174/1381612826666210101152352.

Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: A review

Liu W, Dong X, Liu Y, Sun Y.

Acta Biomater. 2021 Mar 15;123:93-109. doi: 10.1016/j.actbio.2021.01.018. Epub 2021 Jan 16.

The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease

Castagna A, Manzo C, Fabbo A, Lacava R, Ruberto C, Ruotolo G.

Clin Drug Investig. 2021 Feb;41(2):177-182. doi: 10.1007/s40261-020-00996-2. Epub 2021 Jan 23.

Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction

Gulcan HO, Orhan IE.

Curr Drug Targets. 2021;22(14):1618-1628. doi: 10.2174/1389450122666210120144921.

Efficacy of Gene Therapy to Restore Cognition in Alzheimer's Disease: A Systematic Review

Tedeschi DV, da Cunha AF, Cominetti MR, Pedroso RV.

Curr Gene Ther. 2021;21(3):246-257. doi: 10.2174/1566523221666210120091146.

Astrocyte subtype-specific approach to Alzheimer's disease treatment

Sarkar S, Biswas SC.

Neurochem Int. 2021 May;145:104956. doi: 10.1016/j.neuint.2021.104956. Epub 2021 Jan 24.

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's

Yang A, Kantor B, Chiba-Falek O.

Int J Mol Sci. 2021 Jan 27;22(3):1244. doi: 10.3390/ijms22031244.

A review on advances of treatment modalities for Alzheimer's disease

Se Thoe E, Fauzi A, Tang YQ, Chamyuang S, Chia AYY.

Life Sci. 2021 Jul 1;276:119129. doi: 10.1016/j.lfs.2021.119129. Epub 2021 Jan 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias